Christopher Carlos, MD, MAS
|
| Title(s) | Assistant Professor, Medicine |
|---|
| School | School of Medicine |
|---|
| Address | 500 Parnassus Avenue, #W418B
San Francisco CA 94117
|
|---|
| Pronouns | He/Him/His |
|---|
| vCard | Download vCard |
|---|
|
|
Biography
| Stanford University, Stanford, CA | BA | 2007 | Human Biology |
| Case Western Reserve University, Cleveland, OH | MD | 2013 | School of Medicine |
| UCSF, San Francisco, CA | Residency | 2016 | Internal Medicine |
| UCSF, San Francisco, CA | Fellowship | 2018 | Nephrology |
| UCSF, San Francisco, CA | MAS | 2019 | Clinical Research |
Overview
Dr. Christopher Carlos is an Assistant Professor within the Division of Nephrology and a board-certified nephrologist. He practices both inpatient and outpatient nephrology. In his outpatient clinic, he specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders.
Dr. Carlos earned his medical degree from Case Western Reserve University School of Medicine. He completed his residency in Internal Medicine at UCSF, where he also completed a fellowship in Nephrology. During his fellowship, he obtained a Master's Degree in Clinical Research from the UCSF School of Epidemiology and Biostatistics. His primary research interest was in the effect of dialysis therapies on physical function and well-being.
He is a member of the American Society of Nephrology and National Kidney Foundation.
Research
ORNG Applications
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022 09; 10(9).
Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE, ICPi-AKI Consortium Investigators. PMID: 36137651; PMCID: PMC9511654.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 10; 102(4):930-935.
Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium. PMID: 35964800; PMCID: PMC9523226.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 10; 9(10).
Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE, ICPi-AKI Consortium Investigators. PMID: 34625513; PMCID: PMC8496384.
View in:
PubMed Mentions:
65 Fields:
Translation:
Humans
-
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study. Journal of Onco-Nephrology. 2021; 5(2):89-95.
Natsuhara KH, Zhang L, Carlos CA, Borno HT. View Publication.
-
Predialysis fluid overload and gait speed: a repeated measures analysis among patients on chronic dialysis. Nephrol Dial Transplant. 2020 06 01; 35(6):1027-1031.
Carlos C, Grimes B, Segal M, Johansen K. PMID: 31886859; PMCID: PMC7282826.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports. Clin J Am Soc Nephrol. 2019 12 06; 14(12):1679-1681.
Carlos CA, Hsu RK. PMID: 31672795; PMCID: PMC6895476.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely? J Am Soc Nephrol. 2017 Aug; 28(8):2521-2528.
Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. PMID: 28336719; PMCID: PMC5533234.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs